ФАКТОРЫ РИСКА РАКА ЯИЧНИКА И ВОЗМОЖНЫЕ ПРЕВЕНТИВНЫЕ СТРАТЕГИИ
Аннотация
Ключевые слова
рак яичников,
скрининг,
профилактика,
BRCA1,
BRCA2,
ovarian cancer,
screening,
prevention,
BRCA1,
BRCA2
Об авторах
О. Б. Карелина
ФГБОУ ВО «Кемеровский государственный медицинский университет» Министерства здравоохранения Российской Федерации
Россия
Россия
Н. В. Артымук
ФГБОУ ВО «Кемеровский государственный медицинский университет» Министерства здравоохранения Российской Федерации
Россия
Россия
Т. И. Фетисова
ФГБОУ ВО «Кемеровский государственный медицинский университет» Министерства здравоохранения Российской Федерации
Россия
Россия
Список литературы
1. Аксель Е.М. Статистика злокачественных новообразований женской половой сферы // Онкогинекология. 2012. № 1. С. 18-23.
2. Состояние онкологической помощи населению России в 2016 году / под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. Москва: МНИОИ им. П.А. Герцена филиал ГБУ «НМИРЦ» Минздрава России, 2017. 236 с.
3. Reed NS, Symonds RP. Ovarian Cancer. Clin Oncol (R Coll Radiol). 2018; 30 (8): 461-462.
4. Prat J, FIGO Committee on Gynecologic Oncology. FIGO’s staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication. J Gynecol Oncol. 2015; 26 (2): 87-89.
5. Pathology of the Ovary, Fallopian Tube and Peritoneum. Wilkinson N [Ed]. London: Springer, 2014. 524 p.
6. Morgan RJ, Armstrong DK, Alvarez RD, Bakkum-Games JN, Behbakht K, Chen L-M, et al. NCCN Clinical Practice Guidelines in Oncology. Epithelial Ovarian Cancer, Including Fallopian Tube Cancer and Primary Peritoneal Cancer. Fort Washington (PA): National Comprehensive Cancer Network; 2015.
7. La Vecchia C. Ovarian cancer: epidemiology and risk factors. Eur J Cancer Prev. 2017; 2 (1): 55-62.
8. Ali AT. Towards prevention of ovarian cancer. Curr Cancer Drug Targets. 2018; 18 (6): 522-537.
9. Chen Y, Du H, Bao L, Liu W. Opportunistic salpingectomy at benign gynecological surgery for reducing ovarian cancer risk: a 10-year single centre experience from China and a literature review. J Cancer. 2018; 9 (1): 141-147.
10. Fukui Y, Taguchi A, Adachi K, Sato M, Kawata A, Tanikawa M, et al. Polycystic ovarian morphology may be a positive prognostic factor in patients with endometrial cancer who achieved complete remission after fertility-sparing therapy with progestin. Asian Pac J Cancer Prev. 2017; 18 (11): 31113116.
11. Ko KP, Kim SJ, Huzarski T, Gronwald J, Lubinski J, Lynch HT, et al. The association between smoking and cancer incidence in BRCA1 and BRCA2 mutation carriers. Int J Cancer. 2018; 142 (11): 2263-2272.
12. Wu D, Yang H, Winham SJ, Natanzon Y, Koestler DC, Luo T, et al. Mediation analysis of alcohol consumption, DNA methylation, and epithelial ovarian cancer. J Hum Genet. 2018; 63 (3): 339-348.
13. Cuello MA, Kato S, Liberona F. The impact on high-grade serous ovarian cancer of obesity and lipid metabolism-related gene expression patterns: the underestimated driving force affecting prognosis. J Cell Mol Med. 2018; 22 (3): 1805-1815.
14. Hirasawa A, Imoto I, Naruto T, Akahane T, Yamagami W, Nomura H, et al. Prevalence of pathogenic germline variants detected by multigene sequencing in unselected Japanese patients with ovarian cancer. Oncotarget. 2017; 8 (68): 112258112267.
15. Fujiwara H, Suzuki M, Takeshima N, Takizawa K, Kimura E, Nakanishi T, et al. Evaluation of human epididymis protein 4 and Risk of Ovarian Malignancy Algorithm as diagnostic tools of type I and type II epithelial ovarian cancer in Japanese women. Tumour Biol. 2015; 3 (2): 1045-1053.
16. Sadlecki P, Jóźwicki J, Antosik P, Grabiec M. Expression of selected epithelial-mesenchymal transition transcription factors in serous borderlineovarian tumors and type I ovarian cancers. Tumour Biol. 2018; 40 (6): 1010428318784807.
17. Borley J, Wilhelm-Benartzi C, Yazbek J, Williamson R, Bharwani N, Stewart V, et al. Radiological predictors of cytoreductive outcomes in patients with advanced ovarian cancer. BJOG. 2015; 122 (6): 843-849.
18. Mukuda N, Fujii S, Inoue C, Fukunaga T, Oishi T, Harada T, et al. Bilateral Ovarian Tumors on MRI: How Should We Differentiate the Lesions? Yonago Acta Med. 2018; 61 (2): 110-116.
19. Schmidt M, Segev Y, Sadeh R, Suzan E, Feferkorn I, Kaldawy A, et al. Cancer antigen 125 levels are significantly associated with prognostic parameters in uterine papillary serous carcinoma. Int J Gynecol Cancer. 2018 Jun 28. doi: 10.1097/ IGC.0000000000001300. [Epub ahead of print].
20. Chien J, Poole EM. Ovarian cancer prevention, screening, and early detection: report from the 11th Biennial Ovarian Cancer Research Symposium. Int J Gynecol Cancer. 2017; 27 (9S Suppl 5): S20-S22.
Рецензия
Для цитирования:
Карелина О.Б., Артымук Н.В., Фетисова Т.И. ФАКТОРЫ РИСКА РАКА ЯИЧНИКА И ВОЗМОЖНЫЕ ПРЕВЕНТИВНЫЕ СТРАТЕГИИ. Фундаментальная и клиническая медицина. 2018;3(3):91-96.
For citation:
Karelina O.B., Artymuk N.V., Fetisova T.I. RISK FACTORS OF OVARIAN CANCER AND POSSIBLE PREVENTIVE STRATEGIES. Fundamental and Clinical Medicine. 2018;3(3):91-96. (In Russ.)
Просмотров: 725
Послать статью по эл. почте 